| Clinical characteristics and day-90 outcomes of 4244 critically ill adults with COVID-19: a prospective cohort study Intensive care medicine 47, 60-73, 2021 | 461 | 2021 |
| Mesenchymal stromal cell therapy in ischemia/reperfusion injury P Rowart, P Erpicum, O Detry, L Weekers, C Grégoire, C Lechanteur, ... Journal of immunology research 2015, 2015 | 140 | 2015 |
| Infusion of third-party mesenchymal stromal cells after kidney transplantation: a phase I-II, open-label, clinical study P Erpicum, L Weekers, O Detry, C Bonvoisin, MH Delbouille, C Grégoire, ... Kidney international 95 (3), 693-707, 2019 | 96 | 2019 |
| mesenchymal stromal cell therapy for inflammatory bowel diseases C Grégoire, C Lechanteur, A Briquet, É Baudoux, F Baron, E Louis, ... Alimentary pharmacology & therapeutics 45 (2), 205-221, 2017 | 87 | 2017 |
| Comparison of mesenchymal stromal cells from different origins for the treatment of graft-vs.-host-disease in a humanized mouse model C Grégoire, C Ritacco, M Hannon, L Seidel, L Delens, L Belle, S Dubois, ... Frontiers in immunology 10, 619, 2019 | 68 | 2019 |
| Characteristics, management, and prognosis of elderly patients with COVID-19 admitted in the ICU during the first wave: insights from the COVID-ICU study: prognosis of COVID-19 … M Dres, D Hajage, S Lebbah, A Kimmoun, T Pham, G Béduneau, ... Annals of intensive care 11 (1), 77, 2021 | 50 | 2021 |
| Rationale for the potential use of mesenchymal stromal cells in liver transplantation M Vandermeulen, C Grégoire, A Briquet, C Lechanteur, Y Beguin, O Detry World Journal of Gastroenterology: WJG 20 (44), 16418, 2014 | 35 | 2014 |
| Extracorporeal membrane oxygenation for severe acute respiratory distress syndrome associated with COVID-19: an emulated target trial analysis D Hajage, A Combes, C Guervilly, G Lebreton, A Mercat, A Pavot, S Nseir, ... American journal of respiratory and critical care medicine 206 (3), 281-294, 2022 | 33 | 2022 |
| Bone marrow-derived mesenchymal stromal cell therapy in severe COVID-19: preliminary results of a phase I/II clinical trial C Grégoire, N Layios, B Lambermont, C Lechanteur, A Briquet, ... Frontiers in immunology 13, 932360, 2022 | 29 | 2022 |
| Allogeneic mesenchymal stromal cells for refractory luminal Crohn’s disease: a phase I–II study C Gregoire, A Briquet, C Pirenne, C Lechanteur, E Louis, Y Beguin Digestive and Liver Disease 50 (11), 1251-1255, 2018 | 28 | 2018 |
| Patient selection for CAR T or BiTE therapy in multiple myeloma: Which treatment for each patient? D Kegyes, C Constantinescu, L Vrancken, L Rasche, C Gregoire, B Tigu, ... Journal of Hematology & Oncology 15 (1), 78, 2022 | 26 | 2022 |
| In vitro Th17-polarized human CD4+ T cells exacerbate xenogeneic graft-versus-host disease L Delens, G Ehx, J Somja, L Vrancken, L Belle, L Seidel, C Grégoire, ... Biology of Blood and Marrow Transplantation 25 (2), 204-215, 2019 | 24 | 2019 |
| Benefits and risks of noninvasive oxygenation strategy in COVID-19: a multicenter, prospective cohort study (COVID-ICU) in 137 hospitals Critical Care 25, 1-13, 2021 | 23 | 2021 |
| Characteristics and prognosis of bloodstream infection in patients with COVID-19 admitted in the ICU: an ancillary study of the COVID-ICU study N Massart, V Maxime, P Fillatre, K Razazi, A Ferré, P Moine, F Legay, ... Annals of Intensive Care 11 (1), 183, 2021 | 19 | 2021 |
| Epidemiology, risk factors and prognosis of ventilator-associated pneumonia during severe COVID-19: Multicenter observational study across 149 European Intensive Care Units M Garnier, JM Constantin, N Heming, L Camous, A Ferré, K Razazi, ... Anaesthesia Critical Care & Pain Medicine 42 (1), 101184, 2023 | 18 | 2023 |
| RETRACTED: human bone marrow, umbilical cord or liver mesenchymal stromal cells fail to improve liver function in a model of CCl4-induced liver damage in NOD/SCID/IL-2Rγ (null … A Briquet, C Grégoire, F Comblain, L Servais, M Zeddou, C Lechanteur, ... Cytotherapy 16 (11), 1511-1518, 2014 | 17 | 2014 |
| Early prone positioning in acute respiratory distress syndrome related to COVID-19: a propensity score analysis from the multicentric cohort COVID-ICU network—the ProneCOVID study C Le Terrier, F Sigaud, S Lebbah, L Desmedt, D Hajage, C Guérin, ... Critical Care 26 (1), 71, 2022 | 16 | 2022 |
| Predicting 90-day survival of patients with COVID-19: Survival of Severely Ill COVID (SOSIC) scores M Schmidt, B Guidet, A Demoule, M Ponnaiah, M Fartoukh, L Puybasset, ... Annals of intensive care 11, 1-15, 2021 | 13 | 2021 |
| Reduced T-cell response following a third dose of SARS-CoV-2 vaccine in infection-naïve people living with HIV M El Moussaoui, S Desmecht, A Tashkeev, N Lambert, N Maes, ... Journal of Infection 85 (6), 702-769, 2022 | 11 | 2022 |
| Limitation of life-sustaining therapies in critically ill patients with COVID-19: a descriptive epidemiological investigation from the COVID-ICU study M Giabicani, C Le Terrier, A Poncet, B Guidet, JP Rigaud, JP Quenot, ... Critical Care 27 (1), 103, 2023 | 6 | 2023 |
